Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study ; volume:39 ; number:1 ; day:22 ; month:11 ; year:2021 ; pages:562-582 ; date:1.2022
Advances in therapy ; 39, Heft 1 (22.11.2021), 562-582, 1.2022
- Creator
-
Kelton, Kari
Klein, Tim
Murphy, Dan
Belger, Mark
Hille, Erik
McCollam, Patrick L.
Spiro, Theodore
Burge, Russel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-021-01982-6
- URN
-
urn:nbn:de:101:1-2022050720235158131191
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kelton, Kari
- Klein, Tim
- Murphy, Dan
- Belger, Mark
- Hille, Erik
- McCollam, Patrick L.
- Spiro, Theodore
- Burge, Russel
- SpringerLink (Online service)
Other Objects (12)
Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China
Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19
Outcomes Among Patients Hospitalized for COVID-19 Treated with Remdesivir in an Urban Center Pre-COVID-19 Vaccination
Remdesivir: A Review in COVID-19
Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab
Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience
Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China
Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19
Outcomes Among Patients Hospitalized for COVID-19 Treated with Remdesivir in an Urban Center Pre-COVID-19 Vaccination
Remdesivir: A Review in COVID-19
Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab
Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience
Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China
Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19
Outcomes Among Patients Hospitalized for COVID-19 Treated with Remdesivir in an Urban Center Pre-COVID-19 Vaccination
Remdesivir: A Review in COVID-19
Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab
Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey